
Viking Therapeutics Inc (NASDAQ:VKTX) shares are falling in Wednesday’s after-hours session after the company reported financial results for the second quarter.
Q2 Earnings: Viking Therapeutics reported a second-quarter loss of 58 cents per share, missing analyst estimates for a loss of 46 cents per share, according to Benzinga Pro.